July 2020 – Proactive Investors: ReNeuron’s Michael Hunt says key focus now is to build dataset for retinal disease study Preliminary Results Presentation for the year ended 31 March 2020 To view the presentation of the preliminary results for the year ended 31 March 2020 please click here. ARM Cell & Gene : Meeting on the Med – 23-25 April 2019 Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation To view the presentation please click here… Proactive Investors : “ReNeuron Group agrees £80mln cell therapy licensing deal for China” https://www.youtube.com/watch?v=H3Ny1KbHusg Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’ https://youtu.be/ADBu4Uy7ZZ0 Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’ Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ Section: News News
Preliminary Results Presentation for the year ended 31 March 2020 To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
ARM Cell & Gene : Meeting on the Med – 23-25 April 2019 Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation To view the presentation please click here… Proactive Investors : “ReNeuron Group agrees £80mln cell therapy licensing deal for China” https://www.youtube.com/watch?v=H3Ny1KbHusg Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’ https://youtu.be/ADBu4Uy7ZZ0 Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’ Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ Section: News News
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation To view the presentation please click here…
Proactive Investors : “ReNeuron Group agrees £80mln cell therapy licensing deal for China” https://www.youtube.com/watch?v=H3Ny1KbHusg
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’ https://youtu.be/ADBu4Uy7ZZ0
Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’ Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ Section: News News
Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ
Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma” https://www.youtube.com/watch?v=wa47CfniyLQ
